Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

Authors: Paul Moayyedi, John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Leanne Dyal, Olga Shestakovska, Darryl P. Leong, Sonia S. Anand, Stefan Störk, Kelley R. Branch, Deepak L. Bhatt, Peter Verhamme, Martin O’Donnell, Aldo P. Maggioni, Eva Lonn, Leopoldo Soares Piegas, Georg Ertl, Mátyás Keltai, Nancy Cook Bruns, Eva Muehlhofer, Gilles R. Dagenais, Jae‐Hyung Kim, Masatsugu Hori, Philippe Gabríel Steg, Robert G. Hart, Rafael Díaz, Marco Alings, Petr Widimský, Álvaro Avezum, Jeffrey L. Probstfield, Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf - Gastroenterology 2019 cited by 154